FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      
1. Name and Address of Reporting Person * Diamond Susan M 2. Issuer Name and Ticker or Trading Symbol HUMANA INC [ HUM ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)_____ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
Chief Financial Officer
(Last)          (First)          (Middle)
HUMANA INC., 500 WEST MAIN STREET
3. Date of Earliest Transaction (MM/DD/YYYY)
11/3/2022
(Street)
LOUISVILLE, KY 40202
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)
 
6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Humana Common  11/3/2022    M    2437  A $350.7875  6399  D   
Humana Common  11/3/2022    M    1508 (12) A $376.61  7907  D   
Humana Common  11/3/2022    S    3945  D $566.3637 (12) 3962  D   
Humana Common  11/3/2022    S    1678  D $565.9866 (12) 2284  D   
Humana Common  11/4/2022    G    100 (13) D $0  2184  D   
Humana Common                 2143  I  See Footnote (1)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Options (2) $350.7875  11/3/2022    M        2437    (2) 2/24/2027  Humana Common  2437  $0  1861  D   
Options (3) $376.61  11/3/2022    M        1508    (3) 2/22/2028  Humana Common  1508  $0  3016  D   
Options (4) $428.6767                   (4) 8/1/2028  Humana Common  3793    3793  D   
Options (5) $425.055                   (5) 2/21/2029  Humana Common  5562    5562  D   
Restricted Stock Units (6)  (6)                  (7)  (7) Humana Common  285    285  D   
Restricted Stock Units (6)  (6)                  (8)  (8) Humana Common  733    733  D   
Restricted Stock Units (6)  (6)                  (9)  (9) Humana Common  622    622  D   
Restricted Stock Units (6)  (6)                  (10)  (10) Humana Common  1535    1535  D   
Phantom Stock Units (11)  (11)                  (11)  (11) Humana Common  320    320  I  See Footnote. (11)

Explanation of Responses:
(1)  Shares held for the benefit of the reporting person as of October 31, 2022 under the Humana Retirement Savings Plan including routine payroll deductions, quarterly dividend allocation, and a routine disposition of shares to fund an administrative fee assessment under a Tax-Conditioned Plan, exempt under Rule 16b-3(c).
(2)  Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2020, vesting in three annual increments from 2/24/21 to 2/24/23.
(3)  Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/22/2021, vesting in three annual increments from 2/22/22 to 2/22/24.
(4)  Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 8/1/2021, vesting in three annual increments from 8/1/22 to 8/1/24.
(5)  Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 2/21/2022, vesting in three annual increments from 2/21/23 to 2/21/25.
(6)  Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).
(7)  Restricted stock units granted to reporting person on 02/24/2020, 33% of the award is vesting on 12/15/20, 12/15/21, and 12/15/22.
(8)  Restricted stock units granted to reporting person on 02/22/2021, 33% of the award is vesting on 12/15/21, 12/15/22, and 12/15/23.
(9)  Restricted stock units granted to reporting person on 08/1/2021, 33% of the award is vesting on 8/1/22, 8/1/23, and 8/1/24.
(10)  Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24.
(11)  Phantom Stock Units held for the benefit of reporting person as of October 31, 2022 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price.
(12)  Price reported is weighted average sales price.
(13)  Shares disposed of represent gift/charitable donation, effective November 4, 2022 in which no value was received in return.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Diamond Susan M
HUMANA INC.
500 WEST MAIN STREET
LOUISVILLE, KY 40202


Chief Financial Officer

Signatures
Susan M. Diamond 11/7/2022
**Signature of Reporting Person Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Humana (NYSE:HUM)
Historical Stock Chart
Von Jan 2023 bis Feb 2023 Click Here for more Humana Charts.
Humana (NYSE:HUM)
Historical Stock Chart
Von Feb 2022 bis Feb 2023 Click Here for more Humana Charts.